• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炔雌醇和炔诺酮治疗对绝经后妇女骨吸收及钙调节激素的早期影响。

Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones.

作者信息

Selby P L, Peacock M, Barkworth S A, Brown W B, Taylor G A

出版信息

Clin Sci (Lond). 1985 Sep;69(3):265-71. doi: 10.1042/cs0690265.

DOI:10.1042/cs0690265
PMID:3933891
Abstract

The early effects of sex steroid therapy were assessed in 28 normal post-menopausal women, 18 treated with ethinyloestradiol and 10 with norethisterone. There was a reduction in the fasting urinary excretion of both calcium and hydroxyproline with both treatments, indicating reduced bone resorption. This was apparent after 1 week of therapy but became more marked after 3 weeks. These changes were not accompanied by any changes in plasma levels of calcitonin or parathyroid hormone. Patients receiving ethinyloestradiol showed a marked increase in plasma 1,25-dihydroxyvitamin D (1,25-(OH)2D) concentration but this was explicable entirely in terms of increased plasma levels of vitamin D binding protein. There was no change in the free plasma level of 1,25(OH)2D. Patients treated with norethisterone showed no increase in plasma concentrations of 1,25(OH)2D. We conclude that both ethinyloestradiol and norethisterone have a rapid and similar effect in reducing bone resorption. This is not mediated via the plasma levels of the calcium regulating hormones.

摘要

对28名绝经后正常女性进行了性类固醇疗法的早期效果评估,其中18名接受乙炔雌二醇治疗,10名接受炔诺酮治疗。两种治疗方法均使钙和羟脯氨酸的空腹尿排泄量减少,表明骨吸收减少。治疗1周后就很明显,但3周后更为显著。这些变化并未伴随降钙素或甲状旁腺激素血浆水平的任何变化。接受乙炔雌二醇治疗的患者血浆1,25 - 二羟维生素D(1,25-(OH)₂D)浓度显著升高,但这完全可以用维生素D结合蛋白血浆水平升高来解释。血浆中游离的1,25(OH)₂D水平没有变化。接受炔诺酮治疗的患者血浆1,25(OH)₂D浓度没有升高。我们得出结论,乙炔雌二醇和炔诺酮在减少骨吸收方面具有快速且相似的效果。这不是通过钙调节激素的血浆水平介导的。

相似文献

1
Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones.炔雌醇和炔诺酮治疗对绝经后妇女骨吸收及钙调节激素的早期影响。
Clin Sci (Lond). 1985 Sep;69(3):265-71. doi: 10.1042/cs0690265.
2
Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.炔雌醇和炔诺酮用于治疗绝经后妇女原发性甲状旁腺功能亢进症。
N Engl J Med. 1986 Jun 5;314(23):1481-5. doi: 10.1056/NEJM198606053142304.
3
The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women.经皮雌激素对绝经后女性骨骼、钙调节激素及肝脏的影响。
Clin Endocrinol (Oxf). 1986 Nov;25(5):543-7. doi: 10.1111/j.1365-2265.1986.tb03607.x.
4
Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis.炔诺酮对绝经后骨质疏松症骨相关生化指标及前臂骨矿物质的影响。
Clin Endocrinol (Oxf). 1993 Dec;39(6):649-55. doi: 10.1111/j.1365-2265.1993.tb02422.x.
5
Changes in vitamin D metabolism during natural and medical menopause.自然绝经和药物性绝经期间维生素D代谢的变化。
J Clin Endocrinol Metab. 1990 Jul;71(1):127-32. doi: 10.1210/jcem-71-1-127.
6
Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.骨质疏松女性在接受雌激素、合成代谢类固醇或降钙素治疗期间的维生素D代谢。
Acta Endocrinol (Copenh). 1990 Jun;122(6):715-21. doi: 10.1530/acta.0.1220715.
7
Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause.绝经后早期外源性性激素对钙调节激素的调控作用
Eur J Clin Invest. 1983 Dec;13(6):481-7. doi: 10.1111/j.1365-2362.1983.tb00133.x.
8
Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.含炔诺酮和炔雌醇甲醚的不同口服避孕药对性激素结合球蛋白的影响。
Br J Obstet Gynaecol. 1980 May;87(5):416-21. doi: 10.1111/j.1471-0528.1980.tb04571.x.
9
Calcium metabolism in post-menopausal women.绝经后女性的钙代谢
Rev Esp Fisiol. 1985 Dec;41(4):447-50.
10
Calcium-regulating hormones across the menstrual cycle.整个月经周期中的钙调节激素。
J Clin Endocrinol Metab. 1986 Jun;62(6):1313-6. doi: 10.1210/jcem-62-6-1313.

引用本文的文献

1
Estrogen Decreases Cytoskeletal Organization by Forming an ERα/SHP2/c-Src Complex in Osteoclasts to Protect against Ovariectomy-Induced Bone Loss in Mice.雌激素通过在破骨细胞中形成雌激素受体α/含Src同源2结构域蛋白2/原癌基因c-Src复合物来减少细胞骨架组织,从而预防小鼠卵巢切除诱导的骨质流失。
Antioxidants (Basel). 2021 Apr 17;10(4):619. doi: 10.3390/antiox10040619.
2
Optimal age of commencing and discontinuing thiazide therapy to protect against fractures.开始和停止噻嗪类药物治疗以预防骨折的最佳年龄。
Osteoporos Int. 2016 May;27(5):1875-85. doi: 10.1007/s00198-015-3451-0. Epub 2015 Dec 11.
3
Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men.
性腺类固醇撤退对男性血清磷酸盐和FGF-23水平的影响。
Bone. 2007 Apr;40(4):913-8. doi: 10.1016/j.bone.2006.10.016. Epub 2006 Dec 8.
4
Radiocalcium absorption is reduced in postmenopausal women with vertebral and most types of peripheral fractures.
Osteoporos Int. 2004 Jan;15(1):27-31. doi: 10.1007/s00198-003-1493-1. Epub 2003 Nov 4.
5
Should the treatment of osteoporosis be more selective?
Osteoporos Int. 2003 Apr;14(2):99-102. doi: 10.1007/s00198-002-1366-z. Epub 2003 Mar 12.
6
Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.雌激素通过直接诱导骨吸收破骨细胞凋亡来抑制骨吸收。
J Exp Med. 1997 Aug 18;186(4):489-95. doi: 10.1084/jem.186.4.489.
7
The effect of estrogen deficiency on bone mineral density, renal calcium and phosphorus handling and calcitropic hormones in the rat.雌激素缺乏对大鼠骨矿物质密度、肾脏钙磷代谢及钙调节激素的影响。
Calcif Tissue Int. 1996 Sep;59(3):174-8. doi: 10.1007/s002239900105.
8
That oestrogen replacement for osteoporosis prevention should no longer be a bone of contention.雌激素替代疗法用于预防骨质疏松症不应再成为争论的焦点。
Ann Rheum Dis. 1993 Jan;52(1):74-80. doi: 10.1136/ard.52.1.74.
9
Does estrogen replacement therapy influence parathyroid hormone responsiveness to exogenous hypercalcemia in postmenopausal women?雌激素替代疗法是否会影响绝经后女性甲状旁腺激素对外源性高钙血症的反应?
J Endocrinol Invest. 1993 May;16(5):323-7. doi: 10.1007/BF03348845.
10
Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss.白细胞介素-1受体拮抗剂的持续保骨作用:关于白细胞介素-1在卵巢切除所致骨质流失中作用的假说
Calcif Tissue Int. 1994 Oct;55(4):260-5. doi: 10.1007/BF00310403.